An Observational, Multinational, Post-Marketing Registry of Omaveloxolone-Treated Patients With Friedreich’s Ataxia

First published 04/10/2024

Last updated 08/04/2025

EU PAS number:

EUPAS1000000196

Study

Ongoing

Download as PDF

Documents

Study protocol

Updated protocol

296FA401_Protocol Amendment 6_Redacted_03 Apr 2025.pdf

First published: 03/04/2025

English (8.05 MB - PDF) View document

Study results

No information provided.

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

An Observational, Multinational, Post-Marketing Registry of Omaveloxolone-Treated Patients With Friedreich’s Ataxia

Secondary tabs

Share this page